MAP3K8 anticorps (AA 277-461)
Aperçu rapide pour MAP3K8 anticorps (AA 277-461) (ABIN2625108)
Antigène
Voir toutes MAP3K8 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 277-461
-
Specificité
- Human MAP3K8 / TPL2
-
Purification
- Immunoaffinity purified
-
Immunogène
-
Human recombinant protein fragment corresponding to amino acids 277-461 of human MAP3K8(NP_005195) produced in E. coli.
Type of Immunogen: Recombinant protein -
Isotype
- IgG1
-
-
-
-
Indications d'application
- Approved: WB (1:500)
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.3, 1 % BSA, 50 % glycerol, 0.02 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Minimize freezing and thawing.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze-thaw cycles.
-
-
- MAP3K8 (Mitogen-Activated Protein Kinase Kinase Kinase 8 (MAP3K8))
-
Autre désignation
- MAP3K8 / TPL2
-
Sujet
-
Name/Gene ID: MAP3K8
Subfamily: MAP3K
Family: Protein Kinase
Synonyms: MAP3K8, C-COT, Cancer Osaka thyroid oncogene, COT, Ewing sarcoma transformant, EST, MEKK8, Proto-oncogene c-Cot, TPL2, Tumor progression locus 2, Protein kinase cot, Tpl-2, ESTF -
ID gène
- 1326
-
NCBI Accession
- NP_005195
-
Pathways
- Signalisation PI3K-Akt, TCR Signaling
Antigène
-